SCHEMBL9982976

SCHEMBL9982976

c1ncc2cnn(N3CCNCC3)c2n1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.34
CYP1A2 P05177 2/20 0.34
CYP3A4 P08684 2/20 0.34
KMT2A Q03164 2/20 0.34
CYP2D6 P10635 1/20 0.34
TSHR P16473 1/20 0.34
RECQL P46063 1/20 0.34
P4HB P07237 1/20 0.33
KDM4E B2RXH2 1/20 0.32
ALDH1A1 P00352 1/20 0.32
HTR1A P08908 1/20 0.32
CYP2C9 P11712 1/20 0.32
HPGD P15428 1/20 0.32
HTR2A P28223 1/20 0.32
HTR2C P28335 1/20 0.32
CYP2C19 P33261 1/20 0.32
HSD17B10 Q99714 1/20 0.32
ADRB2 P07550 1/20 0.31
PIM1 P11309 1/20 0.31
PIM3 Q86V86 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4996004 0.81 MEN1 (0.36) MEN1KMT2AKDM4E
Hydrochloric Acid SCHEMBL3714263 0.75 HTR2C (0.43) KDM4EALDH1A1HTR1AHTR2AHTR2C
SCHEMBL20658216 0.71 NPC1 (0.37) CYP1A2CYP3A4KMT2ARECQLKDM4E
SCHEMBL4185095 0.70 ALDH1A1 (0.41) MEN1CYP1A2CYP3A4KMT2ACYP2D6
SCHEMBL2507997 0.68 FDPS (0.35) MEN1CYP1A2CYP3A4KMT2ACYP2D6
SCHEMBL9983256 0.67 MERTK (0.40)
SCHEMBL29521086 0.67 HTR2C (0.41) CYP1A2CYP3A4CYP2D6TSHRRECQL
SCHEMBL8470553 0.67 HTR2C (0.41) CYP1A2CYP3A4CYP2D6TSHRRECQL
Hydrochloric Acid SCHEMBL10583863 0.66 ADRA2A (0.41) CYP1A2CYP3A4CYP2D6TSHRRECQL
SCHEMBL9982855 0.64 PIM1 (0.33) KDM4EPIM1PIM3PIM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8076338-B2 Such as 6-(4-phenylpiperazin-1-yl)-9H-purine; cell proliferation/differentiation EXELIXIS, INC. (US) 2011-12-13 US disclosed